European Pharmaceutical Review’s podcasts interview some of the leading experts and scientists about the latest developments in the pharmaceutical and life science sectors.
European Pharmaceutical Review podcast
Claim This Podcastby European Pharmaceutical Review
4.9(9 reviews)
26 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇬🇧
Podcast Overview
European Pharmaceutical Review’s podcasts interview some of the leading experts and scientists about the latest developments in the pharmaceutical and life science sectors.
Language
🇺🇲
Publishing Since
4/30/2021
Reach the team behind European Pharmaceutical Review podcast
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
June 25, 2024
EPR Podcast Episode 26 – Navigating Nitrosamine Impurities – Jason Brown, Adare Pharma Solutions
<img width="375" height="196" src="https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Podcast-graphic-1-375x196.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="Podcast graphic- EPR Podcast Ep 26 – Navigating Nitrosamine Impurities" style="float: left; margin-right: 5px;" link_thumbnail="" decoding="async" fetchpriority="high" srcset="https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Podcast-graphic-1-375x196.jpg 375w, https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Podcast-graphic-1-750x393.jpg 750w, https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Podcast-graphic-1-768x402.jpg 768w, https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Podcast-graphic-1.jpg 1200w" sizes="(max-width: 375px) 100vw, 375px" /><p>In this podcast, Jason Brown, Senior Manager, Analytical Sciences, R&D, Adare Pharma Solutions, discusses the current landscape and the best approaches for mitigating contamination and detecting nitrosamines.</p> <p>The post <a href="https://www.europeanpharmaceuticalreview.com/podcasts/epr-podcast-episode-26-navigating-nitrosamine-impurities-jason-brown-adare-pharma-solutions/">EPR Podcast Episode 26 – Navigating Nitrosamine Impurities – Jason Brown, Adare Pharma Solutions</a> appeared first on <a href="https://www.europeanpharmaceuticalreview.com">European Pharmaceutical Review</a>.</p>
May 29, 2024
EPR Podcast 25 – FAIR Data in Pharma – Giovanni Nisato, Pistoia Alliance
<img width="375" height="196" src="https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Podcast-graphic-2-375x196.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="Podcast graphic - FAIR data" style="float: left; margin-right: 5px;" link_thumbnail="" decoding="async" fetchpriority="high" srcset="https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Podcast-graphic-2-375x196.jpg 375w, https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Podcast-graphic-2-750x393.jpg 750w, https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Podcast-graphic-2-768x402.jpg 768w, https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Podcast-graphic-2.jpg 1200w" sizes="(max-width: 375px) 100vw, 375px" /><p>In this podcast, Giovanni Nisato, Project Manager at the Pistoia Alliance discusses data integrity and the progress towards implementation of FAIR data principles in the pharmaceutical industry.</p> <p>The post <a href="https://www.europeanpharmaceuticalreview.com/podcasts/epr-podcast-25-fair-data-in-pharma-giovanni-nisato-pistoia-alliance/">EPR Podcast 25 – FAIR Data in Pharma – Giovanni Nisato, Pistoia Alliance</a> appeared first on <a href="https://www.europeanpharmaceuticalreview.com">European Pharmaceutical Review</a>.</p>
April 30, 2024
EPR Podcast 24 – Developing modifier gene therapy – Ocugen
<img width="375" height="196" src="https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Podcast-graphic-375x196.jpg" class="webfeedsFeaturedVisual wp-post-image" alt="Podcast 24 – Developing modifier gene therapy for Ocular diseases" style="float: left; margin-right: 5px;" link_thumbnail="" decoding="async" fetchpriority="high" srcset="https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Podcast-graphic-375x196.jpg 375w, https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Podcast-graphic-750x393.jpg 750w, https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Podcast-graphic-768x402.jpg 768w, https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Podcast-graphic.jpg 1200w" sizes="(max-width: 375px) 100vw, 375px" /><p>In this podcast, Dr Neena Haider, Faculty at Harvard Medical School and Dr Arun Upadhyay, Chief Scientific Officer at Ocugen, discuss the development of modifier gene therapy for ocular diseases.</p> <p>The post <a href="https://www.europeanpharmaceuticalreview.com/podcasts/epr-podcast-24-developing-modifier-gene-therapy/">EPR Podcast 24 – Developing modifier gene therapy – Ocugen</a> appeared first on <a href="https://www.europeanpharmaceuticalreview.com">European Pharmaceutical Review</a>.</p>
26 total episodes available
Deep-dive analytics for European Pharmaceutical Review podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is European Pharmaceutical Review podcast?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.